{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:04Z","timestamp":1792788364714,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Beijing Municipalit","award":["L212051"],"award-info":[{"award-number":["L212051"]}]},{"name":"Clinical Cohort Construction Program of Peking University Third Hospital","award":["BYSYDL2022018"],"award-info":[{"award-number":["BYSYDL2022018"]}],"id":[{"id":"https:\/\/ror.org\/04wwqze12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20091-8","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:21:44Z","timestamp":1783016504000},"page":"9483-9495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Tumor Size on Therapeutic Decision-Making for Upper Tract Urothelial Carcinoma: A Large-Scale Population Analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Peng","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"5","key":"20091_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523\u20135.","journal-title":"J Urol."},{"issue":"2","key":"20091_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","volume":"69","author":"T Kondo","year":"2007","unstructured":"Kondo T, Nakazawa H, Ito F, et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology. 2007;69(2):265\u20139.","journal-title":"Urology."},{"issue":"6","key":"20091_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","volume":"95","author":"GD Stewart","year":"2005","unstructured":"Stewart GD, Bariol SV, Grigor KM, et al. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int. 2005;95(6):791\u20133.","journal-title":"BJU Int."},{"issue":"4","key":"20091_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","volume":"76","author":"R Abouassaly","year":"2010","unstructured":"Abouassaly R, Alibhai SM, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology. 2010;76(4):895\u2013901.","journal-title":"Urology."},{"issue":"2","key":"20091_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.urology.2009.10.004","volume":"75","author":"C Jeldres","year":"2010","unstructured":"Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology. 2010;75(2):315\u201320.","journal-title":"Urology."},{"issue":"10232","key":"20091_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395(10232):1268\u201377.","journal-title":"Lancet."},{"issue":"25","key":"20091_CR7","first-page":"00145","volume":"S0302\u20132838","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol. 2025;S0302\u20132838(25):00145\u20139.","journal-title":"Eur Urol."},{"issue":"9","key":"20091_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","volume":"106","author":"E Pieras","year":"2010","unstructured":"Pieras E, Frontera G, Ruiz X, et al. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int. 2010;106(9):1319\u201323.","journal-title":"BJU Int."},{"issue":"3","key":"20091_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11255-013-0533-9","volume":"46","author":"D Milenkovic-Petronic","year":"2014","unstructured":"Milenkovic-Petronic D, Milojevic B, Djokic M, et al. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol. 2014;46(3):563\u20139.","journal-title":"Int Urol Nephrol."},{"issue":"8","key":"20091_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1464-410X.2008.08134.x","volume":"103","author":"G Simone","year":"2009","unstructured":"Simone G, Papalia R, Loreto A, et al. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int. 2009;103(8):1052\u20137.","journal-title":"BJU Int."},{"key":"20091_CR11","doi-asserted-by":"publisher","first-page":"4368943","DOI":"10.1155\/2016\/4368943","volume":"2016","author":"X Su","year":"2016","unstructured":"Su X, Fang D, Li X, et al. The influence of tumor size on oncologic outcomes for patients with upper tract urothelial carcinoma after radical nephroureterectomy. Biomed Res Int. 2016;2016:4368943.","journal-title":"Biomed Res Int."},{"issue":"6","key":"20091_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bju.13463","volume":"118","author":"Y Shibing","year":"2016","unstructured":"Shibing Y, Liangren L, Qiang W, et al. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases. BJU Int. 2016;118(6):902\u201310.","journal-title":"BJU Int."},{"issue":"5","key":"20091_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.urolonc.2013.11.006","volume":"32","author":"PN Espiritu","year":"2014","unstructured":"Espiritu PN, Sverrisson EF, Sexton WJ, et al. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection. Urol Oncol. 2014;32(5):619\u201324.","journal-title":"Urol Oncol."},{"issue":"2","key":"20091_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.euf.2021.03.003","volume":"8","author":"C Coll\u00e0 Ruvolo","year":"2022","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF, et al. Tumor size predicts muscle-invasive and non-organ-confined disease in upper tract urothelial carcinoma at radical nephroureterectomy. Eur Urol Focus. 2022;8(2):498\u2013505.","journal-title":"Eur Urol Focus."},{"issue":"5","key":"20091_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","volume":"182","author":"H Isbarn","year":"2009","unstructured":"Isbarn H, Jeldres C, Shariat SF, et al. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol. 2009;182(5):2177\u201381.","journal-title":"J Urol."},{"key":"20091_CR16","unstructured":"National Cancer Institute. Overview of the SEER program. https:\/\/ seer.cancer.gov\/about\/overview.html."},{"key":"20091_CR17","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021;96:106165.","journal-title":"Int J Surg."},{"key":"20091_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.euros.2022.06.001","volume":"42","author":"R Ma","year":"2022","unstructured":"Ma R, Liu Z, Cheng Y, et al. Prognostic value of tumor size in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis. Eur Urol Open Sci. 2022;42:19\u201329.","journal-title":"Eur Urol Open Sci."},{"issue":"3","key":"20091_CR19","doi-asserted-by":"publisher","first-page":"272.e1","DOI":"10.1016\/j.clgc.2020.09.002","volume":"19","author":"B Foerster","year":"2021","unstructured":"Foerster B, Abufaraj M, Mari A, et al. The performance of tumor size as risk stratification parameter in upper tract urothelial carcinoma (UTUC). Clin Genitourin Cancer. 2021;19(3):272.e1-272.e7.","journal-title":"Clin Genitourin Cancer."},{"issue":"4","key":"20091_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.urology.2007.06.1106","volume":"70","author":"KS Cho","year":"2007","unstructured":"Cho KS, Hong SJ, Cho NH, et al. Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology. 2007;70(4):662\u20136.","journal-title":"Urology."},{"issue":"4","key":"20091_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010;57(4):575\u201381.","journal-title":"Eur Urol."},{"issue":"2","key":"20091_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","volume":"61","author":"TF Chromecki","year":"2012","unstructured":"Chromecki TF, Cha EK, Fajkovic H, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2012;61(2):245\u201353.","journal-title":"Eur Urol."},{"issue":"5","key":"20091_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","volume":"55","author":"T Hisataki","year":"2000","unstructured":"Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology. 2000;55(5):663\u20137.","journal-title":"Urology."},{"issue":"2","key":"20091_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000050969","volume":"67","author":"F Koga","year":"2001","unstructured":"Koga F, Nagamatsu H, Ishimaru H, et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int. 2001;67(2):135\u201341.","journal-title":"Urol Int."},{"issue":"5","key":"20091_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/MOU.0b013e328363212b","volume":"23","author":"M Kathrins","year":"2013","unstructured":"Kathrins M, Caesar S, Mucksavage P, et al. Renal mass size: concordance between pathology and radiology. Curr Opin Urol. 2013;23(5):389\u201393.","journal-title":"Curr Opin Urol."},{"issue":"4","key":"20091_CR26","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.urology.2006.04.042","volume":"68","author":"JA Kanofsky","year":"2006","unstructured":"Kanofsky JA, Phillips CK, Stifelman MD, et al. Impact of discordant radiologic and pathologic tumor size on renal cancer staging. Urology. 2006;68(4):728\u201331.","journal-title":"Urology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20091-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:00Z","timestamp":1789667580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20091"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20091-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors affirm that the research was conducted without any commercial or financial associations that might be perceived as potential conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval from the institutional review committee or patient consent was required for this study due to the SEER database is publicly accessible and contains no identifiable patient information.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication not applicable as this article contained no individual person\u2019s data.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}